Industry Growth Insights published a new data on “Medical Second Opinion Market”. The research report is titled “Medical Second Opinion Market research by Types (Hospitals, Medical Second Opinion Providing Companies, Health Insurance Companies, Medical Second Opinio), By Applications (Cancer, Diabetes, Cardiac Disorders, Neurological Disorders, Ocular Disorders, Others), By Players/Companies HCA Hospitals, AXA PPP Healthcare, Royal London Group, Helsana Group, Cleveland Clinic, Amradnet, Best Doctors Inc, Inova Care, Toranomon Hospital, Keio University Hospital, Johns Hopkins Medicine, Penn Medicine, Oncology International Pvt. Ltd., GrandOpinion, London Pain Clinic, Mondial Assistance, Medisense, Medo Asia Sdn. Bhd., Medical Second Opinio”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Medical Second Opinion Market Research Report
By Type
Hospitals, Medical Second Opinion Providing Companies, Health Insurance Companies, Medical Second Opinio
By Application
Cancer, Diabetes, Cardiac Disorders, Neurological Disorders, Ocular Disorders, Others
By Companies
HCA Hospitals, AXA PPP Healthcare, Royal London Group, Helsana Group, Cleveland Clinic, Amradnet, Best Doctors Inc, Inova Care, Toranomon Hospital, Keio University Hospital, Johns Hopkins Medicine, Penn Medicine, Oncology International Pvt. Ltd., GrandOpinion, London Pain Clinic, Mondial Assistance, Medisense, Medo Asia Sdn. Bhd., Medical Second Opinio
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
231
Number of Tables & Figures
162
Customization Available
Yes, the report can be customized as per your need.
Global Medical Second Opinion Market Report Segments:
The global Medical Second Opinion market is segmented on the basis of:
Types
Hospitals, Medical Second Opinion Providing Companies, Health Insurance Companies, Medical Second Opinio
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Cancer, Diabetes, Cardiac Disorders, Neurological Disorders, Ocular Disorders, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- HCA Hospitals
- AXA PPP Healthcare
- Royal London Group
- Helsana Group
- Cleveland Clinic
- Amradnet
- Best Doctors Inc
- Inova Care
- Toranomon Hospital
- Keio University Hospital
- Johns Hopkins Medicine
- Penn Medicine
- Oncology International Pvt. Ltd.
- GrandOpinion
- London Pain Clinic
- Mondial Assistance
- Medisense
- Medo Asia Sdn. Bhd.
- Medical Second Opinio
Highlights of The Medical Second Opinion Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Hospitals
- Medical Second Opinion Providing Companies
- Health Insurance Companies
- Medical Second Opinio
- By Application:
- Cancer
- Diabetes
- Cardiac Disorders
- Neurological Disorders
- Ocular Disorders
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Medical Second Opinion Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Medical second opinion is a consultation with another doctor who can provide an independent assessment of the patient's medical condition. This service may be requested by the patient or their health care provider in order to gain more information about a particular medical issue.
Some of the major companies in the medical second opinion market are HCA Hospitals, AXA PPP Healthcare, Royal London Group, Helsana Group, Cleveland Clinic, Amradnet, Best Doctors Inc, Inova Care, Toranomon Hospital, Keio University Hospital, Johns Hopkins Medicine, Penn Medicine, Oncology International Pvt. Ltd., GrandOpinion, London Pain Clinic, Mondial Assistance, Medisense, Medo Asia Sdn. Bhd., Medical Second Opinio.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Medical Second Opinion Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Medical Second Opinion Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Medical Second Opinion Market - Supply Chain
4.5. Global Medical Second Opinion Market Forecast
4.5.1. Medical Second Opinion Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Medical Second Opinion Market Size (000 Units) and Y-o-Y Growth
4.5.3. Medical Second Opinion Market Absolute $ Opportunity
5. Global Medical Second Opinion Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Medical Second Opinion Market Size and Volume Forecast by Type
5.3.1. Hospitals
5.3.2. Medical Second Opinion Providing Companies
5.3.3. Health Insurance Companies
5.3.4. Medical Second Opinio
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Medical Second Opinion Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Medical Second Opinion Market Size and Volume Forecast by Application
6.3.1. Cancer
6.3.2. Diabetes
6.3.3. Cardiac Disorders
6.3.4. Neurological Disorders
6.3.5. Ocular Disorders
6.3.6. Others
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Medical Second Opinion Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Medical Second Opinion Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Medical Second Opinion Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Medical Second Opinion Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Medical Second Opinion Demand Share Forecast, 2019-2026
9. North America Medical Second Opinion Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Medical Second Opinion Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Medical Second Opinion Market Size and Volume Forecast by Application
9.4.1. Cancer
9.4.2. Diabetes
9.4.3. Cardiac Disorders
9.4.4. Neurological Disorders
9.4.5. Ocular Disorders
9.4.6. Others
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Medical Second Opinion Market Size and Volume Forecast by Type
9.7.1. Hospitals
9.7.2. Medical Second Opinion Providing Companies
9.7.3. Health Insurance Companies
9.7.4. Medical Second Opinio
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Medical Second Opinion Demand Share Forecast, 2019-2026
10. Latin America Medical Second Opinion Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Medical Second Opinion Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Medical Second Opinion Market Size and Volume Forecast by Application
10.4.1. Cancer
10.4.2. Diabetes
10.4.3. Cardiac Disorders
10.4.4. Neurological Disorders
10.4.5. Ocular Disorders
10.4.6. Others
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Medical Second Opinion Market Size and Volume Forecast by Type
10.7.1. Hospitals
10.7.2. Medical Second Opinion Providing Companies
10.7.3. Health Insurance Companies
10.7.4. Medical Second Opinio
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Medical Second Opinion Demand Share Forecast, 2019-2026
11. Europe Medical Second Opinion Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Medical Second Opinion Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Medical Second Opinion Market Size and Volume Forecast by Application
11.4.1. Cancer
11.4.2. Diabetes
11.4.3. Cardiac Disorders
11.4.4. Neurological Disorders
11.4.5. Ocular Disorders
11.4.6. Others
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Medical Second Opinion Market Size and Volume Forecast by Type
11.7.1. Hospitals
11.7.2. Medical Second Opinion Providing Companies
11.7.3. Health Insurance Companies
11.7.4. Medical Second Opinio
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Medical Second Opinion Demand Share, 2019-2026
12. Asia Pacific Medical Second Opinion Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Medical Second Opinion Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Medical Second Opinion Market Size and Volume Forecast by Application
12.4.1. Cancer
12.4.2. Diabetes
12.4.3. Cardiac Disorders
12.4.4. Neurological Disorders
12.4.5. Ocular Disorders
12.4.6. Others
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Medical Second Opinion Market Size and Volume Forecast by Type
12.7.1. Hospitals
12.7.2. Medical Second Opinion Providing Companies
12.7.3. Health Insurance Companies
12.7.4. Medical Second Opinio
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Medical Second Opinion Demand Share, 2019-2026
13. Middle East & Africa Medical Second Opinion Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Medical Second Opinion Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Medical Second Opinion Market Size and Volume Forecast by Application
13.4.1. Cancer
13.4.2. Diabetes
13.4.3. Cardiac Disorders
13.4.4. Neurological Disorders
13.4.5. Ocular Disorders
13.4.6. Others
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Medical Second Opinion Market Size and Volume Forecast by Type
13.7.1. Hospitals
13.7.2. Medical Second Opinion Providing Companies
13.7.3. Health Insurance Companies
13.7.4. Medical Second Opinio
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Medical Second Opinion Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Medical Second Opinion Market: Market Share Analysis
14.2. Medical Second Opinion Distributors and Customers
14.3. Medical Second Opinion Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. HCA Hospitals
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. AXA PPP Healthcare
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Royal London Group
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Helsana Group
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Cleveland Clinic
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Amradnet
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Best Doctors Inc
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Inova Care
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Toranomon Hospital
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Keio University Hospital
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. Johns Hopkins Medicine
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. Penn Medicine
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. Oncology International Pvt. Ltd.
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. GrandOpinion
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. London Pain Clinic
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. Mondial Assistance
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. Medisense
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. Medo Asia Sdn. Bhd.
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. Medical Second Opinio
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook